Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Industry Focus Switzerland.
Press releases published on April 24, 2025
TradersYard launches free trading tournaments to help aspiring traders experience financial markets without risk
EIN Presswire
·
April 24, 2025
New “Survivor Showdown” Tournament Inspired by Viral Challenge Concepts Offers Cash and Prop Trading Prizes — Sponsorship Opportunities Now Available VIENNA, AUSTRIA, April 24, 2025 /EINPresswire.com/ -- TradersYard, the award-winning platform …
Quarero Robotics beruft James McCain in den Beirat und nutzt dessen militärische und geheimdienstliche Erfahrung
EIN Presswire
·
April 24, 2025
ZUG, SWITZERLAND, April 24, 2025 /EINPresswire.com/ -- Quarero Robotics, ein Schweizer Vorreiter für KI-gestützte autonome Sicherheitssysteme, gibt mit Freude die Ernennung von James McCain in seinen Beirat bekannt. McCain ist ein hochdekorierter …
XploraDEX $XPL Token Distribution Ongoing—Only 5 Days Left to Join Presale Before the Window Closes
GlobeNewswire
·
April 24, 2025
ZURICH, April 24, 2025 (GLOBE NEWSWIRE) -- With the $XPL token distribution in full swing, investors are now deep into the final countdown. Only 5 days remain for the public to join $XRP Presale and secure early access to what is rapidly being hailed as …
Starke Verkäufe von Cresemba® (Isavuconazol) in Japan lösen zweite Umsatzmeilensteinzahlung von Asahi Kasei Pharma an Basilea aus
GlobeNewswire
·
April 24, 2025
Allschwil, 24. April 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren Infektionen durch Bakterien oder Pilze erkrankt sind, …
Strong sales for Cresemba® (isavuconazole) in Japan trigger second milestone payment from Asahi Kasei Pharma to Basilea
GlobeNewswire
·
April 24, 2025
Allschwil, Switzerland, April 24, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported today that the sales of …
Addex Therapeutics to Release Full-Year 2024 Financial Results and Host Conference Call on April 25, 2025
GlobeNewswire
·
April 24, 2025
Geneva, Switzerland, April 24, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will …
STMicroelectronics Reports 2025 First Quarter Financial Results
GlobeNewswire
·
April 24, 2025
PR No: C3332C STMicroelectronics Reports 2025 First Quarter Financial Results Q1 net revenues $2.52 billion; gross margin 33.4%; operating income $3 million; net income $56 million Business outlook at mid-point: Q2 net revenues of $2.71 billion and gross …
STMicroelectronics annonce ses résultats financiers du premier trimestre 2025
GlobeNewswire
·
April 24, 2025
PR No: C3332C STMicroelectronics annonce ses résultats financiers du premier trimestre 2025 Premier trimestre : chiffre d’affaires net de 2,52 milliards de dollars ; marge brute de 33,4 % ; résultat d’exploitation de 3 millions de dollars ; résultat net de …
Sportradar Announces Pricing of Public Offering of Class A Ordinary Shares by Selling Shareholders and Concurrent Share Repurchase
GlobeNewswire
·
April 24, 2025
ST. GALLEN, Switzerland, April 24, 2025 (GLOBE NEWSWIRE) -- Sportradar Group AG (Nasdaq: SRAD) (“Sportradar” or the “Company”) today announced the pricing of the previously announced secondary public offering of an aggregate of 23,000,000 Class A ordinary …